RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

CAPSTONE INVESTMENT ADVISORS, LLC's Holding History (CIK: 0001426196)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 40,303 Value ($000) $204 Avg Close $4.91 Range $3.79 - $6.11
Q1 2024
Shares 16,100 Value ($000) $161 Avg Close $11.14 Range $8.68 - $15.74